EXV4.DE vs. GN0M.DE
EXV4.DE (iShares STOXX Europe 600 Health Care UCITS ETF (DE)) and GN0M.DE (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds - EXV4.DE tracks the STOXX® Europe 600 Health Care while GN0M.DE tracks the Solactive Genomics. Both are passively managed. Over the past 3 years, EXV4.DE returned 2.32%/yr vs -1.90%/yr for GN0M.DE. At a 0.42 correlation, their price movements are largely independent. EXV4.DE charges 0.46%/yr vs 0.50%/yr for GN0M.DE.
Performance
EXV4.DE vs. GN0M.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXV4.DE achieves a -2.60% return, which is significantly lower than GN0M.DE's 12.99% return.
EXV4.DE
- 1D
- 2.82%
- 1M
- 0.11%
- YTD
- -2.60%
- 6M
- -1.19%
- 1Y
- 4.38%
- 3Y*
- 2.32%
- 5Y*
- 4.98%
- 10Y*
- 5.78%
GN0M.DE
- 1D
- 5.61%
- 1M
- 13.54%
- YTD
- 12.99%
- 6M
- 10.44%
- 1Y
- 55.70%
- 3Y*
- -1.90%
- 5Y*
- —
- 10Y*
- —
EXV4.DE vs. GN0M.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | -2.60% | 7.23% | 3.85% | 7.52% | -6.10% | 1.11% |
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 12.99% | 5.67% | -12.40% | -9.04% | -32.50% | -7.90% |
Correlation
The correlation between EXV4.DE and GN0M.DE is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Nov 12, 2021 | 0.42 |
The correlation between EXV4.DE and GN0M.DE shifts across timeframes, from 0.41 (3 years) to 0.52 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXV4.DE vs. GN0M.DE — Risk / Return Rank
EXV4.DE
GN0M.DE
EXV4.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EXV4.DE | GN0M.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.71 | ||
| Sortino ratioReturn per unit of downside risk | -2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.33 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | 3.32 | -2.94 |
| Martin ratioReturn relative to average drawdown | 0.84 | 8.35 | -7.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EXV4.DE | GN0M.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 2.00 | -1.71 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | -0.34 | +0.66 |
Drawdowns
EXV4.DE vs. GN0M.DE - Drawdown Comparison
The maximum EXV4.DE drawdown since its inception was -44.54%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for EXV4.DE and GN0M.DE.
Loading charts...
Drawdown Indicators
| EXV4.DE | GN0M.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.54% | -67.19% | +22.65% |
Max Drawdown (1Y)Largest decline over 1 year | -12.57% | -16.68% | +4.11% |
Max Drawdown (3Y)Largest decline over 3 years | -26.55% | -48.32% | +21.77% |
Max Drawdown (5Y)Largest decline over 5 years | -26.55% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -26.55% | — | — |
Current DrawdownCurrent decline from peak | -11.65% | -41.03% | +29.38% |
Average DrawdownAverage peak-to-trough decline | -11.17% | -43.13% | +31.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.72% | 6.65% | -0.93% |
Volatility
EXV4.DE vs. GN0M.DE - Volatility Comparison
The current volatility for iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) is 5.58%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 8.15%. This indicates that EXV4.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXV4.DE | GN0M.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.58% | 8.15% | -2.57% |
Volatility (6M)Calculated over the trailing 6-month period | 11.86% | 19.69% | -7.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.68% | 27.68% | -11.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.55% | 31.49% | -15.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.74% | 31.49% | -15.75% |
EXV4.DE vs. GN0M.DE - Expense Ratio Comparison
EXV4.DE has a 0.46% expense ratio, which is lower than GN0M.DE's 0.50% expense ratio.
Dividends
EXV4.DE vs. GN0M.DE - Dividend Comparison
EXV4.DE's dividend yield for the trailing twelve months is around 1.61%, while GN0M.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXV4.DE iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 1.61% | 1.58% | 1.45% | 1.60% | 1.59% | 1.47% | 1.24% | 1.79% | 1.85% | 2.64% | 2.90% | 2.60% |
GN0M.DE Global X Genomics & Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
EXV4.DE and GN0M.DE have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, EXV4.DE is cheaper at 0.46% per year. The better choice depends on whether you care most about return, fees, risk, or income.
EXV4.DE is cheaper with a 0.46% expense ratio, compared with 0.50% for GN0M.DE.
EXV4.DE tracks STOXX® Europe 600 Health Care, while GN0M.DE tracks Solactive Genomics. They also come from different issuers: iShares and Global X. Their fees differ too: 0.46% for EXV4.DE and 0.50% for GN0M.DE.
Find the right allocation for EXV4.DE and GN0M.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer